Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 1
2014 5
2015 7
2016 2
2017 10
2018 4
2019 9
2020 4
2021 2
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group. Gatta G, et al. Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4. Lancet Oncol. 2017. PMID: 28687376 Free article.
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group. Ray-Coquard I, et al. Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2017.09.025. Epub 2017 Nov 3. Eur J Surg Oncol. 2019. PMID: 29108961 Review.
Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia.
Bösch F, Brüwer K, Altendorf-Hofmann A, Auernhammer CJ, Spitzweg C, Westphalen CB, Boeck S, Schubert-Fritschle G, Werner J, Heinemann V, Kirchner T, Angele M, Knösel T. Bösch F, et al. Among authors: schubert fritschle g. Endocr Relat Cancer. 2019 Mar 1;26(3):293-301. doi: 10.1530/ERC-18-0494. Endocr Relat Cancer. 2019. PMID: 30608901
Risk of metastasis in breast cancer through delay in start of primary therapy.
Halfter K, Schlesinger-Raab A, Schubert-Fritschle G, Hölzel D. Halfter K, et al. Among authors: schubert fritschle g. Lancet Reg Health Eur. 2023 Jun;29:100645. doi: 10.1016/j.lanepe.2023.100645. Epub 2023 May 1. Lancet Reg Health Eur. 2023. PMID: 37153855 Free PMC article. No abstract available.
41 results